Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 6


Cannabinoids for treatment of Alzheimer's disease: moving toward the clinic.

Aso E, Ferrer I.

Front Pharmacol. 2014 Mar 5;5:37. doi: 10.3389/fphar.2014.00037. eCollection 2014. Review.


Endocannabinoids prevent β-amyloid-mediated lysosomal destabilization in cultured neurons.

Noonan J, Tanveer R, Klompas A, Gowran A, McKiernan J, Campbell VA.

J Biol Chem. 2010 Dec 3;285(49):38543-54. doi: 10.1074/jbc.M110.162040. Epub 2010 Oct 5.


Alzheimer's disease; taking the edge off with cannabinoids?

Campbell VA, Gowran A.

Br J Pharmacol. 2007 Nov;152(5):655-62. Epub 2007 Sep 10. Review.


The endocannabinoid system as an emerging target of pharmacotherapy.

Pacher P, Bátkai S, Kunos G.

Pharmacol Rev. 2006 Sep;58(3):389-462. Review.


Harm reduction--the cannabis paradox.

Melamede R.

Harm Reduct J. 2005 Sep 22;2:17.


The ALIAmide palmitoylethanolamide and cannabinoids, but not anandamide, are protective in a delayed postglutamate paradigm of excitotoxic death in cerebellar granule neurons.

Skaper SD, Buriani A, Dal Toso R, Petrelli L, Romanello S, Facci L, Leon A.

Proc Natl Acad Sci U S A. 1996 Apr 30;93(9):3984-9.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk